Emerging technologies, such as nanotechnology and biotechnology, present new challenges and opportunities in toxicology. Nanoparticles, due to their small size and unique properties, may interact with biological systems in unforeseen ways, necessitating novel testing methods. Biotechnology advances, such as genetic engineering and synthetic biology, require updated toxicological evaluations to address potential risks. These technologies also offer tools for more precise and comprehensive toxicological assessments.
